Lixisenatide Added to Basal Insulin Reduces Glycemic Variability in T2DM Patients

被引：0
|
作者：
Umpierrez, Guillermo E.
Digenio, Andres
Goldenberg, Ronald
Hernandez-Triana, Eric
Lin, Jay
O'Neal, David
Park, Cheol-Young
Renard, Eric
Kovatchev, Boris
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1012-P
引用
收藏
页码：A260 / A260
页数：1
相关论文
共 50 条
  • [1] Lixisenatide Significantly Improves Glycemic Control in Asian Patients with T2DM Insufficiently Controlled on Basal Insulin±SU
    Seino, Yutaka
    Min, Kyungwan
    Niemoeller, Elisabeth
    Takami, Akane
    [J]. DIABETES, 2011, 60 : A76 - A76
  • [2] Achieving Postprandial Glucose Control with Lixisenatide (LIXI) Improves Glycemic Control in T2DM Patients (Pts) on Basal Insulin
    Davidson, Jaime A.
    Stager, William
    Paranjape, Sachin
    Berria, Rachele
    Leiter, Lawrence A.
    [J]. DIABETES, 2015, 64 : A299 - A299
  • [3] Lixisenatide added to basal insulin reduces glycaemic variability in patients with type 2 diabetes mellitus
    O'Neal, D.
    Umpierrez, G.
    DiGenio, A.
    Goldenberg, R.
    Hernandez-Triana, E.
    Lin, J.
    Park, C. -Y.
    Renard, E.
    Kovatchev, B.
    [J]. DIABETOLOGIA, 2014, 57 : S342 - S342
  • [4] Adjunctive Lixisenatide Treatment Improves Glycemic Control in Patients with T2DM Irrespective of β-Cell Function
    Yabe, Daisuke
    Ambos, Anu
    Cariou, Bertrand
    Gonzalez-Galvez, Guillermo
    Ikeda, Yukio
    O'Shea, Donal
    De Pablos-Velasco, Pedro
    Smircic-Duvnjak, Lea
    Yale, Jean-Francois
    Evans, Marc
    [J]. DIABETES, 2014, 63 : A253 - A253
  • [5] Hyperglycemia Drives Glycemic Variability in Patients with Type 2 Diabetes (T2DM)
    Olawsky, Evan A.
    Zhang, Yuan
    Alvear, Alison C.
    Eberly, Lynn E.
    Chow, Lisa S.
    [J]. DIABETES, 2020, 69
  • [6] Unmet Needs and Treatment Patterns of T2DM Patients with Basal Insulin
    Dalal, Mehul
    Grabner, Michael
    Gidaya, Nicole
    Bieszk, Nella
    Digenio, Andres
    [J]. DIABETES, 2014, 63 : A232 - A232
  • [7] Basal insulin persistence in Brazilian participants with T2DM
    Franco, Denise Reis
    Perez-Nieves, Magaly
    Ivanova, Jasmina I.
    Cao, Dachuang
    Caselato Vaz, Marcela Saturnino
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (10): : 1254 - 1264
  • [8] Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial
    Ting-Ting Yin
    Yan Bi
    Ping Li
    Shan-Mei Shen
    Xiao-Lu Xiong
    Li-Jun Gao
    Can Jiang
    Yan Wang
    Wen-Huan Feng
    Da-Long Zhu
    [J]. Diabetes Therapy, 2018, 9 : 1253 - 1267
  • [9] Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial
    Yin, Ting-Ting
    Bi, Yan
    Li, Ping
    Shen, Shan-Mei
    Xiong, Xiao-Lu
    Gao, Li-Jun
    Jiang, Can
    Wang, Yan
    Feng, Wen-Huan
    Zhu, Da-Long
    [J]. DIABETES THERAPY, 2018, 9 (03) : 1253 - 1267
  • [10] Efficacy of biphasic insulin aspart 70/30 in patients with T2DM not achieving glycemic targets on OADs with/without basal insulin therapy
    Jain, R
    Allen, E
    Wahl, T
    Wahlen, J
    Bressler, P
    Deng, L
    Garber, A
    [J]. DIABETES, 2005, 54 : A69 - A69
12345